SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1

BACKGROUND: COVID-19 can cause multiple organ damages as well as metabolic abnormalities such as hyperglycemia, insulin resistance, and new onset of diabetes. The insulin/IGF signaling pathway plays an important role in regulating energy metabolism and cell survival, but little is known about the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jihoon, Toyoda, Shinichiro, Nishitani, Shigeki, Onodera, Toshiharu, Fukuda, Shiro, Kita, Shunbun, Fukuhara, Atsunori, Shimomura, Iichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173833/
https://www.ncbi.nlm.nih.gov/pubmed/35688210
http://dx.doi.org/10.1016/j.metabol.2022.155236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173833/
https://www.ncbi.nlm.nih.gov/pubmed/35688210
http://dx.doi.org/10.1016/j.metabol.2022.155236

Ejemplares similares